A multidisciplinary review of the policy, intellectual property rights, and international trade environment for access and affordability to essential cancer medications

• 主要な著者: Sangita M. Baxi (著者), Reed Beall (著者), Joshua Yang (著者), Tim K. Mackey (著者)
• フォーマット: 図書
• 出版事項: BMC, 2019-09-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Abstract In 2015, the World Health Organization (WHO) Expert Committee approved the addition of 16 cancer medicines to the WHO Model List of Essential Medicines (EML), bringing the total number of cancer medicines on the list to 46. This change represented the first major revision to the EML oncolog...